“We are very pleased to receive this positive coverage decision from UnitedHealthcare. As health plans continue to update their coverage policies to include Inspire therapy, an increasing number of patients and physicians will have access to our innovative therapy,” Inspire CEO Tim Herbert said in a statement.
“With the addition of UnitedHealthcare, we now have 35 coverage policies, representing approximately 125 million members, that cover Inspire therapy compared to 3 million members one year ago."
Inspire Medical shares were trading higher by 6.81% at the time of publication Monday, while UnitedHealth shares were down 0.26%.
Karyopharm Spikes Higher After Selinexor Leak
Varian Will Acquire Embolic Bead Asset From Boston Scientific
Photo courtesy of Inspire Medical Systems.
See more from Benzinga
- ChromaDex Shares Nicotinamide Riboside Study Results
- Sol-Gel Technologies Shares Positive Results For Skin Breakout Cream
- Intra-Celluar Therapies Falls Following Results For Treatment Of Bipolar Depression
© 2019 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.